Literature DB >> 18559415

Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression.

Ellen Frank1, Giovanni B Cassano, Paola Rucci, Andrea Fagiolini, Luca Maggi, Helena C Kraemer, David J Kupfer, Bruce Pollock, Robert Bies, Vishwajit Nimgaonkar, Paul Pilkonis, M Katherine Shear, Wesley K Thompson, Victoria J Grochocinski, Paolo Scocco, Joan Buttenfield, Rocco Nicola Forgione.   

Abstract

BACKGROUND: To date, no cross-national RCT has addressed the mechanisms underlying the relative success of pharmacological and psychotherapeutic interventions for depression. A multi-site clinical trial that includes psychotherapy as one of the treatments presents numerous challenges related to cross-site consistency and communication.
PURPOSE: This report describes how those challenges were met in the study "Depression: The Search for Treatment Relevant Phenotypes'', being carried out at the University of Pittsburgh and the University of Pisa, Italy.
METHODS: Implementing the study required the investigators to address methodological and practical challenges related to the different requirements of the two Institutional Review Boards (IRBs), psychotherapy training, independent evaluator training, patient recruitment, development of common tools for data entry, quality control and generation of weekly reports of patient progress as well as establishing a similar clinical and research framework in two countries with substantially different health care systems.
RESULTS: By having bilingual investigators and staff members who spent time at one another's sites, making use of frequent conference-call staff meetings and being flexible within the bounds of the sometimes contradictory requirements of the IRBs, the investigators were able to meet the human subjects protection requirements of both institutions, surmount language barriers to consistent therapist and evaluator training and develop common tools for study management. As a result, recruitment goals were met at both sites and retention rates were high. One instance of inconsistent implementation of the protocol was corrected within the first year. LIMITATIONS: This study was conducted in two Western cultures by researchers with long-standing collaboration. Our findings may not be generalizable to other countries or research settings.
CONCLUSIONS: The implementation of a cross-national protocol and the adoption and maintenance of common procedures is possible when investigators are aware of the challenges this may present and are proactive in trying to address them.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559415      PMCID: PMC3387666          DOI: 10.1177/1740774508091965

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  33 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.

Authors:  Paul W Armstrong; Christopher B Granger; Peter X Adams; Christian Hamm; David Holmes; William W O'Neill; Thomas G Todaro; Alec Vahanian; Frans Van de Werf
Journal:  JAMA       Date:  2007-01-03       Impact factor: 56.272

Review 4.  Interpersonal psychotherapy. Current status.

Authors:  M M Weissman; J C Markowitz
Journal:  Arch Gen Psychiatry       Date:  1994-08

5.  The EORTC Gastrointestinal Tract Cancer Group: 40 years of research contributing to improved GI cancer management.

Authors:  O Anak; E Van Cutsem; B Nordlinger
Journal:  Eur J Cancer       Date:  2002-03       Impact factor: 9.162

6.  Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors.

Authors:  E Frank; D J Kupfer; E F Wagner; A B McEachran; C Cornes
Journal:  Arch Gen Psychiatry       Date:  1991-12

7.  Interpersonal psychotherapy (IPT) and drugs in the treatment of depression.

Authors:  G L Klerman; M M Weissmann
Journal:  Pharmacopsychiatry       Date:  1987-01       Impact factor: 5.788

8.  Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program.

Authors:  S M Sotsky; D R Glass; M T Shea; P A Pilkonis; J F Collins; I Elkin; J T Watkins; S D Imber; W R Leber; J Moyer
Journal:  Am J Psychiatry       Date:  1991-08       Impact factor: 18.112

9.  A comparison of delivery methods of cognitive-behavioral therapy for panic disorder: an international multicenter trial.

Authors:  Justin A Kenardy; Michael G T Dow; Derek W Johnston; Michelle G Newman; Aileen Thomson; C Barr Taylor
Journal:  J Consult Clin Psychol       Date:  2003-12

Review 10.  Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions.

Authors:  Nicola Casacalenda; J Christopher Perry; Karl Looper
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112

View more
  17 in total

1.  Does psychomotor retardation define a clinically relevant phenotype of unipolar depression?

Authors:  S Calugi; G B Cassano; A Litta; P Rucci; A Benvenuti; M Miniati; L Lattanzi; V Mantua; V Lombardi; A Fagiolini; E Frank
Journal:  J Affect Disord       Date:  2010-09-15       Impact factor: 4.839

2.  Gender moderates the relationship between mania spectrum and serotonin transporter polymorphisms in depression.

Authors:  P Rucci; V L Nimgaonkar; H Mansour; M Miniati; I Masala; A Fagiolini; G B Cassano; E Frank
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-10-05       Impact factor: 3.568

3.  The factor structure of lifetime depressive spectrum in patients with unipolar depression.

Authors:  G B Cassano; A Benvenuti; M Miniati; S Calugi; M Mula; L Maggi; P Rucci; A Fagiolini; F Perris; E Frank
Journal:  J Affect Disord       Date:  2008-10-22       Impact factor: 4.839

4.  Comparative outcomes among the problem areas of interpersonal psychotherapy for depression.

Authors:  J C Levenson; E Frank; Y Cheng; P Rucci; C A Janney; P Houck; R N Forgione; H A Swartz; J M Cyranowski; A Fagiolini
Journal:  Depress Anxiety       Date:  2010-05       Impact factor: 6.505

5.  Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study.

Authors:  Alette M Wessels; Yuyan Jin; Bruce G Pollock; Ellen Frank; Anne-Catherine Lange; Bernard Vrijens; Andrea Fagiolini; David J Kupfer; Paola Rucci; Gail Kepple; Joel Anderton; Joan Buttenfield; Robert R Bies
Journal:  Int Clin Psychopharmacol       Date:  2012-11       Impact factor: 1.659

6.  The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy.

Authors:  Jessica C Levenson; Meredith L Wallace; Jay C Fournier; Paola Rucci; Ellen Frank
Journal:  J Consult Clin Psychol       Date:  2012-07-23

7.  Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.

Authors:  E Frank; G B Cassano; P Rucci; W K Thompson; H C Kraemer; A Fagiolini; L Maggi; D J Kupfer; M K Shear; P R Houck; S Calugi; V J Grochocinski; P Scocco; J Buttenfield; R N Forgione
Journal:  Psychol Med       Date:  2010-04-12       Impact factor: 7.723

8.  A Bayesian regression model for multivariate functional data.

Authors:  Ori Rosen; Wesley K Thompson
Journal:  Comput Stat Data Anal       Date:  2009-04-08       Impact factor: 1.681

9.  Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).

Authors:  Joan E Hilner; Letitia H Perdue; Elizabeth G Sides; June J Pierce; Ana M Wägner; Alan Aldrich; Amanda Loth; Lotte Albret; Lynne E Wagenknecht; Concepcion Nierras; Beena Akolkar
Journal:  Clin Trials       Date:  2010-07-05       Impact factor: 2.486

10.  Effect of age, weight, and CYP2C19 genotype on escitalopram exposure.

Authors:  Yuyan Jin; Bruce G Pollock; Ellen Frank; Giovanni B Cassano; Paola Rucci; Daniel J Müller; James L Kennedy; Rocco Nicola Forgione; Margaret Kirshner; Gail Kepple; Andrea Fagiolini; David J Kupfer; Robert R Bies
Journal:  J Clin Pharmacol       Date:  2009-10-19       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.